Journal article
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Abstract
BACKGROUND: The use of anticoagulant therapy during pregnancy is challenging because of the potential for both fetal and maternal complications. This guideline focuses on the management of VTE and thrombophilia as well as the use of antithrombotic agents during pregnancy.
METHODS: The methods of this guideline follow the Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and …
Authors
Bates SM; Greer IA; Middeldorp S; Veenstra DL; Prabulos A-M; Vandvik PO
Journal
CHEST Journal, Vol. 141, No. 2, pp. e691s–e736s
Publisher
Elsevier
Publication Date
February 2012
DOI
10.1378/chest.11-2300
ISSN
0012-3692
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Abortion, SpontaneousAnticoagulantsAntiphospholipid SyndromeDose-Response Relationship, DrugEvidence-Based MedicineFemaleFibrinolytic AgentsHeparinHeparin, Low-Molecular-WeightHumansPregnancyPregnancy Complications, CardiovascularRisk FactorsSecondary PreventionSocieties, MedicalThrombophiliaVenous Thromboembolism